| Financial Year |
March 31 2023 |
| Monetary Funds |
1,138,611,354.58 |
| Held-for-trading Financial Assets |
310,569,219.18 |
| Notes Receivable |
-- |
| Accounts Receivable |
22,592,177.08 |
| Advances to Suppliers |
20,393,539.70 |
| Other Receivables |
18,211,274.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
386,080,246.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
174,663,078.19 |
| Total Current Assets |
2,071,120,889.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
174,343,528.08 |
| Investment Properties |
6,651,351.96 |
| Fixed Assetes |
1,625,167,824.85 |
| Under-construction Projects |
222,576,825.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
164,356,262.78 |
| R&D expenses |
-- |
| Goodwill |
53,118,339.45 |
| Long-Term Deferred and Prepaid Expenses |
165,581,409.95 |
| Deferred Income Tax Assets |
32,972,000.97 |
| Other Non-Current Assets |
9,325,520.24 |
| Sub-Total of Non-Current Assets |
3,169,152,920.69 |
| Total Assets |
5,240,273,810.65 |
| Short-Term Loans |
4,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
157,486,392.92 |
| Accounts Received In Advance |
1,305,743.63 |
| Employee Compensation Payable |
52,140,836.61 |
| Taxes Payable |
26,298,594.43 |
| Interest Payable |
-- |
| Dividend Payable |
37,837,518.70 |
| Other payables |
146,109,471.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
25,392,601.86 |
| Other Current Liabilities |
1,229,732.07 |
| Sub-Total of Current Liabilities |
436,640,822.59 |
| Long-term Loans |
143,222,248.55 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
40,585,788.80 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
19,687,349.64 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
444,306,616.49 |
| Total Liabilities |
880,947,439.08 |
| Paid-In Capital(Or Share Stock) |
729,379,440.00 |
| Capital Surplus |
367,331,765.73 |
| Surplus Reserve |
375,683,134.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,670,362,110.91 |
| Minority Stockholder's Interest |
207,183,329.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,152,143,041.64 |
| Owner's Equity（Stockholder's Equity） |
4,359,326,371.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,240,273,810.65 |
